TY - JOUR AU - Parkin, D. AU - Bray, F. AU - Devesa, S. PY - 2001 DA - 2001// TI - Cancer burden in the year 2000. The global picture JO - Eur J Can VL - 37 UR - https://doi.org/10.1016/S0959-8049(01)00267-2 DO - 10.1016/S0959-8049(01)00267-2 ID - Parkin2001 ER - TY - STD TI - Cancer Stats Incidence. [http://info.cancerresearchuk.org/cancerstats] UR - http://info.cancerresearchuk.org/cancerstats ID - ref2 ER - TY - STD TI - Cancer Stat Fact Sheet- Cancer of the pancreas. [http://seer.cancer.gov/statfacts/html/pancreas.html] UR - http://seer.cancer.gov/statfacts/html/pancreas.html ID - ref3 ER - TY - JOUR AU - Jemal, A. AU - Siegel, R. AU - Ward, E. AU - Hao, Y. AU - Xu, J. AU - Murray, T. AU - Thun, M. J. PY - 2008 DA - 2008// TI - Cancer statistics, 2008 JO - CA: a cancer journal for clinicians VL - 58 ID - Jemal2008 ER - TY - JOUR AU - Shore, S. AU - Raraty, M. AU - Ghaneh, P. AU - Neoptolemos, J. PY - 2003 DA - 2003// TI - Chemotherapy for pancreatic cancer JO - Aliment Pharmacol Ther VL - 18 UR - https://doi.org/10.1111/j.1365-2036.2003.01781.x DO - 10.1111/j.1365-2036.2003.01781.x ID - Shore2003 ER - TY - JOUR AU - Burris, H. AU - Moore, M. AU - Andersen, J. PY - 1997 DA - 1997// TI - Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomised trial JO - J Clin Oncol VL - 15 ID - Burris1997 ER - TY - JOUR AU - Sultana, A. AU - Tudur Smith, C. AU - Cunningham, D. AU - Starling, N. AU - Neoptolemos, J. AU - Ghaneh, P. PY - 2007 DA - 2007// TI - Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.09.2551 DO - 10.1200/JCO.2006.09.2551 ID - Sultana2007 ER - TY - JOUR AU - Moore, M. J. AU - Goldstein, D. AU - Hamm, J. PY - 2007 DA - 2007// TI - Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.07.9525 DO - 10.1200/JCO.2006.07.9525 ID - Moore2007 ER - TY - JOUR AU - Reilly, R. PY - 2006 DA - 2006// TI - Radioimmunotherapy of solid tumors: the promise of pretargeting strategies using bispecific antibodies and radiolabeled haptens JO - J Nucl Med VL - 47 ID - Reilly2006 ER - TY - JOUR AU - Goel, A. AU - Batra, S. PY - 2001 DA - 2001// TI - Antibody constructs for radioimmunodiagnosis and treatment of human pancreatic cancer JO - Teratogenesis, Carcinogenesis, and Mutagenesis VL - 21 UR - https://doi.org/3.0.CO;2-A DO - 3.0.CO;2-A ID - Goel2001 ER - TY - JOUR AU - Benchimol, S. AU - Fuks, A. AU - Jothy, S. AU - Beauchemin, N. AU - Shirota, K. AU - Stanners, C. PY - 1989 DA - 1989// TI - Carcino-embryonic antigen, a human tumour marker, functions as an intercellular adhesion molecule JO - Cell VL - 57 UR - https://doi.org/10.1016/0092-8674(89)90970-7 DO - 10.1016/0092-8674(89)90970-7 ID - Benchimol1989 ER - TY - JOUR AU - Goldenberg, D. AU - Sharkey, R. AU - Primus, F. PY - 1976 DA - 1976// TI - Carcino-embryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections JO - J Natl Cancer Inst VL - 57 ID - Goldenberg1976 ER - TY - JOUR AU - Grunert, F. AU - Luckenbach, G. AU - Haderlie, B. AU - Schwarz, K. AU - von Kleist, S. PY - 1983 DA - 1983// TI - Comparison of colon, lung, and breast-derived carcinoembryonic antigen and cross-reacting antigens by monoclonal antibodies and fingerprint analysis JO - Ann N Y Acad Sci VL - 417 UR - https://doi.org/10.1111/j.1749-6632.1983.tb32851.x DO - 10.1111/j.1749-6632.1983.tb32851.x ID - Grunert1983 ER - TY - JOUR AU - Goldenberg, D. AU - Sharkey, R. AU - Paganelli, G. AU - Barbet, J. AU - Chatal, J. PY - 2006 DA - 2006// TI - Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.03.8471 DO - 10.1200/JCO.2005.03.8471 ID - Goldenberg2006 ER - TY - JOUR AU - Adams, G. AU - Weiner, L. PY - 2005 DA - 2005// TI - Monoclonal antibody therapy of cancer JO - Nature Biotechnology VL - 23 UR - https://doi.org/10.1038/nbt1137 DO - 10.1038/nbt1137 ID - Adams2005 ER - TY - JOUR AU - Behr, T. AU - Liersch, T. AU - Greiner-Bechert, L. AU - Greisinger, F. AU - Behe, M. AU - Markus, P. AU - Gratz, S. AU - Angerstein, C. AU - Brittinger, G. AU - Becker, H. PY - 2002 DA - 2002// TI - Radioimmunotherapy of small-volume disease of metastatic colorectal cancer JO - Cancer VL - 94 UR - https://doi.org/10.1002/cncr.10308 DO - 10.1002/cncr.10308 ID - Behr2002 ER - TY - JOUR AU - Behr, T. AU - Salib, A. AU - Liersch, T. AU - Behe, M. AU - Angerstein, C. AU - Blumenthal, R. AU - Fayyazi, A. AU - Sharkey, R. AU - Ringe, B. AU - Becker, H. PY - 1999 DA - 1999// TI - Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study JO - Clin Cancer Res VL - 5 ID - Behr1999 ER - TY - JOUR AU - Aigner, K. AU - Gailhoter, S. AU - Kopp, S. PY - 1998 DA - 1998// TI - Regional versus systemic chemotherapy for advanced pancreatic cancer: a randomised study JO - Hepatogastroenterology VL - 45 ID - Aigner1998 ER - TY - JOUR AU - Kemeny, N. AU - Niedzwiecki, D. AU - Hollis, D. PY - 2006 DA - 2006// TI - Hepatic arterial infusion versus sytemic therapy for hepatic metastases from colorectal cancer: a randomised trial of efficacy, quality of life, and molecular markers (CALGB 9481) JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.03.8166 DO - 10.1200/JCO.2005.03.8166 ID - Kemeny2006 ER - TY - JOUR AU - Yamaguchi, K. AU - Enjoji, M. AU - Tsuneyoshi, M. PY - 1991 DA - 1991// TI - Pancreatoduodenal carcinoma: a clinicopathologic study of 304 patients and immunohistochemical observation for CEA and CA19-9 JO - J Surg Oncol VL - 47 UR - https://doi.org/10.1002/jso.2930470303 DO - 10.1002/jso.2930470303 ID - Yamaguchi1991 ER - TY - JOUR AU - Engelhardt, K. AU - Riley, C. AU - Cooke, L. AU - Mahadevan, D. PY - 2006 DA - 2006// TI - Monoclonal antibody therapies targeting pancreatic ductal adenocarcinoma JO - Current Drug Discovery Technologies VL - 3 UR - https://doi.org/10.2174/157016306780368108 DO - 10.2174/157016306780368108 ID - Engelhardt2006 ER - TY - JOUR AU - Mabrut, J. Y. AU - Fernandez-Cruz, L. AU - Azagra, J. S. AU - Bassi, C. AU - Delvaux, G. AU - Weerts, J. AU - Fabre, J. M. AU - Boulez, J. AU - Baulieux, J. AU - Peix, J. L. PY - 2005 DA - 2005// TI - Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients JO - Surgery VL - 137 UR - https://doi.org/10.1016/j.surg.2005.02.002 DO - 10.1016/j.surg.2005.02.002 ID - Mabrut2005 ER - TY - JOUR AU - Osborne, J. AU - Harrison, P. AU - Butcher, R. AU - Ebsworth, N. AU - Tan, K. PY - 1999 DA - 1999// TI - Novel super-high affinity sheep monoclonal antibodies against CEA bind colon and lung adenocarcinoma JO - Hybridoma VL - 18 UR - https://doi.org/10.1089/hyb.1999.18.183 DO - 10.1089/hyb.1999.18.183 ID - Osborne1999 ER - TY - CHAP PY - 2004 DA - 2004// TI - Anti-CEA monoclonal antibody KAb 201 radiolabelled with 131 Iodine BT - Xenova Biomedix ID - ref24 ER - TY - JOUR AU - Vinjamuri, S. AU - Sultana, A. AU - Shore, S. AU - Ghaneh, P. AU - Neoptolemos, J. PY - 2004 DA - 2004// TI - Feasibility of using iodine-131 labelled super-high affinity chimaeric antibody targeted against CEA in patients with pancreatic cancer JO - Cancer Biotherapy and Radiopharmaceuticals VL - 19 ID - Vinjamuri2004 ER - TY - JOUR AU - Therasse, P. AU - Arbuck, S. AU - Eisenhauer, E. PY - 2000 DA - 2000// TI - New Guidelines to evaluate the response to treatment in solid tumours JO - Journal of the National Cancer Institute VL - 92 UR - https://doi.org/10.1093/jnci/92.3.205 DO - 10.1093/jnci/92.3.205 ID - Therasse2000 ER - TY - STD TI - Cancer Therapy Evaluation Program CTCAE/CTC Archive. [http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_archive] UR - http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_archive ID - ref27 ER - TY - CHAP AU - Kelsey, J. AU - Whittemore, A. AU - Evans, A. AU - Thompson, W. PY - 1996 DA - 1996// BT - Methods in observational epidemiology PB - Oxford University Press CY - New York ID - Kelsey1996 ER - TY - JOUR AU - Hajjar, G. AU - Sharkey, R. AU - Burton, J. PY - 2002 DA - 2002// TI - Phase I radioimmunotherapy trial with iodine-131-babeled humanised MN-14 anti-carcinoembryonic antigen monoclonal antibody in patients with metastatic gastrointestinal and colorectal cancer JO - Clin Colorectal Cancer VL - 2 UR - https://doi.org/10.3816/CCC.2002.n.009 DO - 10.3816/CCC.2002.n.009 ID - Hajjar2002 ER - TY - STD TI - Knox S, Goris M, Tempero M, Weiden P, Gentner L, Breitz H, Adams G, Axworthy D, Gaffigan S, Bryan K, et al: Phase II trial of Yttrium-90-DOTA-Biotin Pretargeted by NR-LU-10 Antibody/Streptavidin in patients with metastatic colon cancer. Clinical Cancer Research. 2000, 406-414. 6 ID - ref30 ER - TY - JOUR AU - Behr, T. M. AU - Sharkey, R. M. AU - Juweid, M. E. PY - 1997 DA - 1997// TI - Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG JO - J Nucl Med VL - 38 ID - Behr1997 ER - TY - JOUR AU - Juweid, M. AU - Sharkey, R. M. AU - Swayne, L. C. AU - Griffiths, G. L. AU - Dunn, R. AU - Goldenberg, D. PY - 1998 DA - 1998// TI - Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anti-carcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancer JO - The Journal of Nuclear Medicine VL - 39 ID - Juweid1998 ER - TY - JOUR AU - Ritter, G. AU - Cohen, L. AU - Williams, C. J. AU - Richards, E. C. AU - Old, L. J. AU - Welt, S. PY - 2001 DA - 2001// TI - Serological analysis of human anti-human responses in colon cancer patients treated with repeated doses of humanised monoclonal antibody A33 JO - Cancer Res VL - 61 ID - Ritter2001 ER - TY - CHAP AU - Cunningham, D. AU - Chau, I. AU - Stocken, D. PY - 2005 DA - 2005// TI - Phase III randomised comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer BT - Eur J Can ID - Cunningham2005 ER - TY - JOUR AU - Jain, R. PY - 1987 DA - 1987// TI - Transport of molecules across tumor vasculature JO - Cancer Metastasis Rev VL - 6 UR - https://doi.org/10.1007/BF00047468 DO - 10.1007/BF00047468 ID - Jain1987 ER - TY - JOUR AU - Oriuchi, N. AU - Higuchi, T. AU - Hanaoka, H. AU - Iida, Y. AU - Endo, K. PY - 2005 DA - 2005// TI - Current status of cancer therapy with radiolabeled monoclonal antibody JO - Annals of Nuclear Medicine VL - 19 UR - https://doi.org/10.1007/BF03027399 DO - 10.1007/BF03027399 ID - Oriuchi2005 ER - TY - JOUR AU - Berlin, J. D. AU - Catalano, P. AU - Thomas, J. P. AU - Kugler, J. W. AU - Haller, D. G. AU - Benson, A. B. PY - 2002 DA - 2002// TI - Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297 JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.11.149 DO - 10.1200/JCO.2002.11.149 ID - Berlin2002 ER - TY - JOUR AU - Colucci, G. AU - Guiliani, F. AU - Gebbia, V. PY - 2002 DA - 2002// TI - Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma JO - Cancer VL - 94 UR - https://doi.org/10.1002/cncr.10323 DO - 10.1002/cncr.10323 ID - Colucci2002 ER - TY - CHAP AU - Reiss, H. AU - Helm, A. AU - Niedergethmann, M. AU - Schmidt-Wolf, I. AU - Moik, M. AU - Hammer, C. AU - Zippel, K. AU - Weigang-Kohler, K. AU - Stauch, M. AU - Oettle, H. PY - 2005 DA - 2005// TI - A randomised, prospective, multicentre, phase III trial of gemcitabine, 5-Fluorouracil, folinic acid versus gemcitabine alone in patients with advanced pancreatic cancer BT - ASCO Annual Meeting: 2005 ID - Reiss2005 ER - TY - CHAP AU - Hermann, R. AU - Bodoky, G. AU - Ruhstaller, T. AU - Glimelius, B. AU - Saletti, P. AU - Bajetta, E. AU - Schueller, J. AU - Bernhard, J. AU - Dietrich, D. AU - Scheithauer, W. PY - 2005 DA - 2005// TI - Gemcitabine plus capecitabine versus gemcitabine alone in locally advanced or metastatic pancreatic cancer. A randomised phase III study of the Swiss Group for Clinical Cancer Research (SAKK) and the Central European Cooperative Oncology Group (CECOG) BT - 2005 ASCO Annual Meeting: 2005; Orlando, USA ID - Hermann2005 ER - TY - JOUR AU - Heinemann, V. AU - Quietzsch, D. AU - Gieseler, F. AU - Gonnermann, M. PY - 2006 DA - 2006// TI - Randomised phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.05.1490 DO - 10.1200/JCO.2005.05.1490 ID - Heinemann2006 ER - TY - JOUR AU - Kraeber-Bodere, F. AU - Rousseau, C. AU - Bodet-Milin, C. PY - 2006 DA - 2006// TI - Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimisation clinical trial JO - J Nucl Med VL - 47 ID - Kraeber-Bodere2006 ER - TY - JOUR AU - Goldenberg, D. AU - Sharkey, R. M. PY - 2006 DA - 2006// TI - Advances in cancer therapy with radiolabeled monoclonal antibodies JO - Q J Nuclear Med Mol Imaging VL - 50 ID - Goldenberg2006 ER - TY - JOUR AU - Gold, D. AU - Modrak, D. AU - Schutsky, K. AU - Cardillo, T. PY - 2004 DA - 2004// TI - Combined 90Yttrium-dota-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft JO - Int J Cancer VL - 109 UR - https://doi.org/10.1002/ijc.20004 DO - 10.1002/ijc.20004 ID - Gold2004 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/9/66/prepub UR - http://www.biomedcentral.com/1471-2407/9/66/prepub ID - ref45 ER -